Oct 5, 2026, 07:34 UTC
Mitsui Chemicals launched a new InnoCell cell culture plate product for culturing organoids used in drug discovery research.
Source:Sep 25, 2026, 20:00 UTC
Japan Investment Corporation (JIC) is negotiating the sale of its subsidiary, semiconductor materials maker JSR, with Mitsubishi Chemical Group and Mitsui Chemicals showing strong interest in acquiring it.
Source:Sep 16, 2026, 22:15 UTC
Mitsui Chemicals shares rose after SMBC Nikko Securities raised its target price.
Source:Sep 11, 2026, 08:01 UTC
Mitsui Chemicals set its September domestic large-lot phenol price at 438.6 yen per kilogram, down 35.4 yen (7%) from the previous month, reflecting lower July import naphtha prices.
Source:Aug 17, 2026, 05:29 UTC
Mitsui Chemicals completed its acquisition of US dental materials maker Ultradent Products on August 14, 2026, earlier than the originally planned September, and aims to generate over $40 million in core operating profit synergies by fiscal 2030.
Source:Jul 15, 2026, 10:52 UTC
Mitsui Chemicals announced on July 15, 2026 that it will integrate its dental 3D printing business into its subsidiary Sun Medical (Moriyama, Shiga Prefecture) by the end of fiscal year 2026.
Source:Jul 8, 2026, 07:01 UTC
TurtleTree and Novonesis entered an exclusive partnership to scale up TurtleTree's precision fermentation platform, starting with lactoferrin, and Novonesis made a minority investment in TurtleTree.
Source: